News | Breast Density | February 20, 2019

Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits

Husband of late co-founder Nancy M. Cappello takes on leadership of advocacy organizations helping increase awareness of effects of breast density on mammography

Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits

February 20, 2019 — The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D., announced her husband Joseph J. Cappello as their new executive director.  For over a decade, Joseph has worked side-by-side as co-founder of the organizations with his wife, earning him a unique perspective of the critical issue on adjunct screening for women with dense breast tissue.

“Duty compels me to carry on my wife’s mission,” said Cappello. “Women have the right to know their breast density status, to have their complete breast health information. This vital piece of information was denied to Nancy when she was originally diagnosed with late stage 3c breast cancer in 2004. As a result of her hard work, 36 states currently mandate physicians to tell their patients their breast density status.

“Now, we are focusing our energies on getting legislation passed in the remaining 14 states” Cappello added.

Science for decades has demonstrated that dense breast tissue is associated with a higher-than-average risk of breast cancer and that dense breast tissue can mask cancers on mammograms, making them impossible to detect. Adjunct screening to mammography, such as ultrasound and magnetic resonance imaging (MRI), significantly increase detection of early cancers in dense breasts.

Nancy Cappello launched the legislative action of her organizations after being diagnosed with advanced-stage breast cancer in 2004 despite decades of normal mammography results. None of her physicians told her that she had dense breast tissue, which had hidden the growing cancer in her breast, and none advised her to get adjunct screening. Her home state of Connecticut passed the first bill in 2009.

Nancy passed away in November due to complications from myelodysplastic syndrome (MDS), a rare form of bone marrow cancer that in some instances may be associated with previous radiation and chemotherapy cancer treatments.

“I am empowered and honored to further the Are You Dense? mission,” said Joseph Cappello, “that being to reduce missed, delayed and advanced stage breast cancer by increasing access to early detection for women with dense breasts leading to reduced harms from aggressive treatments and better survival outcomes.”

For more information: www.areyoudense.org, www.areyoudenseadvocacy.org

Related Content

iCAD Reports Strong Momentum of ProFound AI for Digital Breast Tomosynthesis
News | Artificial Intelligence | March 26, 2019
iCAD Inc. reported strong adoption of its latest deep-learning, cancer detection software solution for digital breast...
Volpara Solutions Expands Relationship With GE Healthcare
News | Breast Density | March 26, 2019
Volpara Solutions announced the launch of an expanded agreement enabling the worldwide distribution of its...
Hologic Opens Learning and Experience Centre in Zaventem, Belgium
News | Women's Health | March 21, 2019
Hologic Inc. opened its first Learning and Experience Centre in Zaventem, Belgium. The state-of-the-art facility...
QTbreasthealth Opens Breast Imaging Center in San Jose
News | Ultrasound Women's Health | March 20, 2019
QTbreasthealth has opened a new center in San Jose, Calif. The new location is now open and booking appointments for...
Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...